125 related articles for article (PubMed ID: 37219816)
21. External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma.
Leijenaar RT; Carvalho S; Hoebers FJ; Aerts HJ; van Elmpt WJ; Huang SH; Chan B; Waldron JN; O'sullivan B; Lambin P
Acta Oncol; 2015; 54(9):1423-9. PubMed ID: 26264429
[TBL] [Abstract][Full Text] [Related]
22. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
[TBL] [Abstract][Full Text] [Related]
23. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
24. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
26. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
27. Primary vs nodal site PET/CT response as a prognostic marker in oropharyngeal squamous cell carcinoma treated with intensity-modulated radiation therapy.
Eckstein JM; Nolan N; Healy E; Wright CL; Jain A; Barney CL; Washington I; McElroy JP; Grecula JC; Wobb JL; Mitchell DL; Miller E; Gamez M; Blakaj D; Diavolitsis V; Bhatt A
Head Neck; 2020 Sep; 42(9):2405-2413. PubMed ID: 32391626
[TBL] [Abstract][Full Text] [Related]
28. Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.
Goenka A; Morris LG; Rao SS; Wolden SL; Wong RJ; Kraus DH; Ohri N; Setton J; Lok BH; Riaz N; Mychalczak BR; Schoder H; Ganly I; Shah JP; Pfister DG; Zelefsky MJ; Lee NY
Int J Cancer; 2013 Sep; 133(5):1214-21. PubMed ID: 23436584
[TBL] [Abstract][Full Text] [Related]
29. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.
Zeng PYF; Cecchini MJ; Barrett JW; Shammas-Toma M; De Cecco L; Serafini MS; Cavalieri S; Licitra L; Hoebers F; Brakenhoff RH; Leemans CR; Scheckenbach K; Poli T; Wang X; Liu X; Laxague F; Prisman E; Poh C; Bose P; Dort JC; Shaikh MH; Ryan SEB; Dawson A; Khan MI; Howlett CJ; Stecho W; Plantinga P; Daniela da Silva S; Hier M; Khan H; MacNeil D; Mendez A; Yoo J; Fung K; Lang P; Winquist E; Palma DA; Ziai H; Amelio AL; Li SS; Boutros PC; Mymryk JS; Nichols AC
EBioMedicine; 2022 Dec; 86():104373. PubMed ID: 36442320
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
[TBL] [Abstract][Full Text] [Related]
31. Cystic cervical lymph nodes of papillary thyroid carcinoma, tuberculosis and human papillomavirus positive oropharyngeal squamous cell carcinoma: utility of deep learning in their differentiation on CT.
Onoue K; Fujima N; Andreu-Arasa VC; Setty BN; Sakai O
Am J Otolaryngol; 2021; 42(5):103026. PubMed ID: 33862564
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
33. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
34. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
[TBL] [Abstract][Full Text] [Related]
35. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
36. Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Rios Velazquez E; Hoebers F; Aerts HJ; Rietbergen MM; Brakenhoff RH; Leemans RC; Speel EJ; Straetmans J; Kremer B; Lambin P
Radiother Oncol; 2014 Dec; 113(3):324-30. PubMed ID: 25443497
[TBL] [Abstract][Full Text] [Related]
37. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
38. An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.
Corredor G; Toro P; Koyuncu C; Lu C; Buzzy C; Bera K; Fu P; Mehrad M; Ely KA; Mokhtari M; Yang K; Chute D; Adelstein DJ; Thompson LDR; Bishop JA; Faraji F; Thorstad W; Castro P; Sandulache V; Koyfman SA; Lewis JS; Madabhushi A
J Natl Cancer Inst; 2022 Apr; 114(4):609-617. PubMed ID: 34850048
[TBL] [Abstract][Full Text] [Related]
39. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
40. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
